Grace & White Inc Northwest Biotherapeutics Inc Transaction History

Grace & White Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 26, 2022	SELL	$0.62 - $0.81 $6,572 - $8,586	-10,600 Reduced 41.89%	14,705 $10,000
Q1 2021 Apr 19, 2021	BUY	$1.32 - $1.63 $19,410 - $23,969	14,705 Added 138.73%	25,305 $38,000
Q4 2020 Jan 25, 2021	BUY	$0.73 - $2.3 $7,738 - $24,379	10,600 New	10,600 $16,000

674K

Ticker NWBO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,037,230,016
Market Cap $290M
Description
Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...

Get notified when there are updates to the investment portfolio of Grace & White Inc , based on Form 13F filings with the SEC.

Stay updated on Grace & White Inc with notifications on news.